Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › (1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase

(1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase

US Patent 6916813 · Granted Jul 12, 2005

Estimated economic value: $25,481,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic heterocyclic compounds useful as IRAK4 inhibitors2025
Tricyclic heteroaryl compounds useful as IRAK4 inhibitors2025
Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibi2025
Benzo[5,6][1,4]dioxino[2,3-b]pyridine compounds useful as IRAK4 inhibitors2025
Preparation method for oxazepine compound2025
Antibacterial aminoglycoside derivatives2025
5-(4-pyridyloxy)pyrazole compounds serving as TGF-βR1 kinase inhibitor2025
Application of monocyclic β-lactam compound in pharmacy2025
Thienopyridinyl and thiazolopyridinyl compounds useful as IRAK4 inhibitors2025
Estrogen receptor antagonist2025
Pyrimidinyl group-containing tricyclic compound serving as c-Met inhibitor2024
Crystal form of hepatitis B surface antigen inhibitor2024